Skip to main content
. 2023 Jul 17;15:485–494. doi: 10.2147/BCTT.S412338

Table 2.

Self-Reported CIA by Means of EORTC QLQ – Items Hair Loss

Scalp Cooling Group (N=75) Control Group (N=38) Group-by-Time Interaction
*EORTC Item Library – Have you lost any hair? Mean (95% CI) Mean (95% CI) P=0.361
Time point 1 (baseline) 1.36 (1.13–1.59) 1.50 (1.17–1.82)
Time point 2 (mid chemotherapy) 3.28 (3.05–3.50) 3.60 (3.28–3.93)
Time point 3 (last CT cycle) 3.08 (2.85–3.30) 3.40 (3.04–3.76)
Time point 4 (3 months after treatment completion) 1.66 (1.40–1.90) 1.56 (1.18–1.93)
Time point 5 (6–9 months after CT completion) 1.24 (0.99–1.48) 1.07 (0.70–1.44)
*EORTC QLQ – Were you upset by the loss of your hair? P=0.073
Time point 1 (baseline) 1.55 (1.25–1.86) 1.97 (1.55–2.40)
Time point 2 (mid chemotherapy) 2.76 (2.5–3.00) 2.56 (2.22–2.93)
Time point 3 (last CT cycle) 2.43 (2.18–2.68) 2.33 (1.96–2.70)
Time point 4 (3 months after treatment completion) 1.93 (1.65–2.21) 1.60 (1.18–2.00)
Time point 5 (6–9 months after CT completion) 1.76 (1.46–2.06) 1.16 (0.72–1.60)
*EORTC QLQ – Have you been upset by how the treatment has affected your hair? P=0.108
Time point 1 (baseline) 1.45 (1.11–1.79) 1.80 (1.36–2.24)
Time point 2 (mid chemotherapy) 2.53 (2.28–2.79) 2.15 (1.79–2.51)
Time point 3 (last CT cycle) 2.25 (1.99–2.50) 2.13 (1.75–2.50)
Time point 4 (3 months after treatment completion) 1.98 (1.70–2.26) 1.70 (1.25–2.14)
Time point 5 (6–9 months after CT completion) 1.87 (1.58–2.15) 1.44 (1.25–2.14)
*EORTC QLQ – Have you had thin or lifeless hair as a result of your disease or treatment? P=0.219
Time point 1 (baseline) 1.21 (0.85–1.57) 1.53 (1.04–2.02)
Time point 2 (mid chemotherapy) 2.29 (2.01–2.57) 2.25 (1.74–2.76)
Time point 3 (last CT cycle) 1.97 (1.67–2.26) 2.42 (1.90–2.93)
Time point 4 (3 months after treatment completion) 1.86 (1.55–2.18) 1.54 (0.99–2.08)
Time point 5 (6–9 months after CT completion) 1.61 (1.31–1.91) 1.53 (1.04–2.02)

Notes: P-values are reported for the group-by-time interaction, ie the group-difference in change over time. *© EORTC Quality of Life Group. All rights reserved.